Pradžia › Antsvoris › Arizona › Tucson
Antsvoris klinikiniai tyrimai Tucson, AZ
15 tyrimai dėl Antsvoris ieško dalyvių vietose Tucson ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.
Oficialus tyrimo tekstas (anglų kalba)
Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Renkami dalyviai3 fazė
- Synexus Clinical Research US, Inc./Orange Grove Family Practice, Tucson
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Renkami dalyviai3 fazė
- University of Arizona, Tucson
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Renkami dalyviai3 fazė
- Tucson Clinical Research Institute, Tucson
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Renkami dalyviai3 fazė
- Novak Clinical Research - Tucson - North La Cholla Boulevard, Tucson
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Renkami dalyviai3 fazė
- Research Site, Tucson
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Renkami dalyviai3 fazė
- Tucson Orthopaedic Institute - North Wyatt Drive, Tucson
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Renkami dalyviai2 fazė
- The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Renkami dalyviai3 fazė
- AURORA-1 Clinical Site, Tucson
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Renkami dalyviai3 fazė
- AURORA-2 Clinical Site, Tucson
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Renkami dalyviai3 fazė
- Arizona Clinical Trials, Tucson
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Renkami dalyviai3 fazė
- Arizona Clinical Trials, Tucson
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Renkami dalyviai3 fazėLaukiami sveiki savanoriai
- ACCOMPLISH-2 Research Site, Tucson
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Renkami dalyviai2 fazė
- The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Renkami dalyviai2 fazė
- Pima Heart, Tucson
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Renkami dalyviai3 fazė
- ACCOMPLISH-1 Research Site, Tucson
Antsvoris tyrimai kituose miestuose
- San Antonio, TX34 tyrimai
- Houston, TX33 tyrimai
- Chicago, IL28 tyrimai
- Orlando, FL27 tyrimai
- Las Vegas, NV23 tyrimai
- Miami, FL23 tyrimai
- Atlanta, GA20 tyrimai
- Dallas, TX20 tyrimai
- New York City, NY19 tyrimai
- Jacksonville, FL19 tyrimai
- Washington, DC19 tyrimai
- Austin, TX18 tyrimai
Kiti tyrimai Tucson
- Krūties vėžys20 tyrimai
- Nedidelinių ląstelių plaučių vėžys17 tyrimai
- Nutukimas17 tyrimai
- Metastatinis vėžys14 tyrimai
- Vėžys (visų tipų)12 tyrimai
- Širdies ir kraujagyslių ligos12 tyrimai
- Storosios ir tiesiosios žarnos vėžys11 tyrimai
- Prostatos vėžys11 tyrimai
- Steatozinė kepenų liga10 tyrimai
- Širdies nepakankamumas10 tyrimai
- Aukštas kraujospūdis10 tyrimai
- 2 tipo cukrinis diabetas10 tyrimai
Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.